Expression of a hyperfusogenic gibbon ape leukemia virus envelope glycoprotein (GALV.fus) from a SIN vector resulted in antitumor activity against human acute myeloid leukemia (AML) xenografts in mice [195]. This evidence concerns the gene FUS and acute myeloid leukemia.